Literature DB >> 3409218

Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors.

W C Hubbard1, M C Alley, T L McLemore, M R Boyd.   

Abstract

The profiles of prostanoid biosynthesis from endogenous arachidonic acid in 16 established cell lines derived from 4 histological classes of human carcinomas were determined by capillary gas chromatography-mass spectrometry. Detectable quantities of prostanoids were isolated from the culture medium of cell lines representative of the different histological classes of human tumors: colorectal adenocarcinomas (one of three cell lines); ovarian adenocarcinomas (one of three cell lines); prostate adenocarcinomas (zero of two cell lines); non-small cell carcinomas of the lung (four of five cell lines); and small cell carcinomas of the lung (zero of three cell lines). Prostaglandins E2 and F2 alpha were the only prostanoids synthesized in detectable quantities. Prostaglandin E2 biosynthesis (mean +/- SD), pmol/10(6) cells, n = 4) in cell lines exhibiting positive prostaglandin H synthase activity was: LoVo (colorectal adenocarcinoma, 0.4 +/- 0.1); A2780 (ovarian adenocarcinoma, 1.3 +/- 0.3); NCI-H322 (bronchioloalveolar cell carcinoma, 8.4 +/- 3.1); NCI-H358 (bronchioloalveolar cell carcinoma, 7.8 +/- 2.4); EKVX (adenocarcinoma of the lung, 21.3 +/- 5.5); and A427 (large cell undifferentiated carcinoma of the lung, 12.6 +/- 2.8). Prostaglandin F2 alpha production (pmol/10(6) cells +/- SD) was: LoVo (0.3 +/- 0.1); NCI-H322 (0.6 +/- 0.2); NCI-H358 (0.4 +/- 0.1); EKVX (1.8 +/- 0.4); and A427 (11.1 +/- 3.1). These findings suggest that within certain limitations cultured tumor cells provide simplified experimental systems for determination of prostaglandin biosynthetic characteristics of human tumors and that prostanoid biosynthesis may be particularly characteristic of certain non-small cell carcinomas of the lung.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409218

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.

Authors:  I Klapan; V Katić; F Culo; V Cuk
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.

Authors:  S B Shappell; W E Boeglin; S J Olson; S Kasper; A R Brash
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 3.  Aspirin, NSAIDs, and digestive tract cancers.

Authors:  M J Thun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

4.  Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.

Authors:  M Schnitzler; T Dwight; B G Robinson
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

5.  Production of prostaglandin E by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue.

Authors:  F Culo; I Klapan; V Katić; T Kolak; B Bakula
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

6.  Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.

Authors:  B A Teicher; T T Korbut; K Menon; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter.

Authors:  Marilee J Wick; Stacy Blaine; Vicki Van Putten; Milene Saavedra; Raphael A Nemenoff
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

8.  Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.

Authors:  Katja Hattar; Rajkumar Savai; Florentine S B Subtil; Jochen Wilhelm; Anja Schmall; Dagmar S Lang; Torsten Goldmann; Bastian Eul; Gabriele Dahlem; Ludger Fink; Ralph-Theo Schermuly; Gamal-Andre Banat; Ulf Sibelius; Friedrich Grimminger; Ekkehard Vollmer; Werner Seeger; Ulrich Grandel
Journal:  Cancer Immunol Immunother       Date:  2012-08-26       Impact factor: 6.968

9.  Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells.

Authors:  Jen-Hui Tsou; Kwang-Yu Chang; Wei-Chiao Wang; Joseph T Tseng; Wu-Chou Su; Liang-Yi Hung; Wen-Chang Chang; Ben-Kuen Chen
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971

10.  Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

Authors:  A Chaudry; S McClinton; L E Moffat; K W Wahle
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.